Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice

Clinical and Experimental Immunology

Volumn 107, Issue 2, 1997, Pages 353-358

  Kojouharoff, G ^a   Hans, W ^a   Obermeler, F ^a   Mannel D N ^a   Andus, T ^a   Scholmerich J ^a   Gross, V ^a   Falk, W ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

dextran sulphate sodium; experimental colitis; IL 1; neutralization; tumour necrosis factor

Indexed keywords

DEXAMETHASONE; DEXTRAN SULFATE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; COLITIS; CONTROLLED STUDY; ENTERITIS; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031015257     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.291-ce1184.x     Document Type: Article

References (30)

1. Reinecker HC, Steffen M, Witthoeft T et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993; 94:174-81.
2. Mahida YR. Wu K, Jewell DP. Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 1989; 30:835-8.
3. Ligumsky M, Simon PL. Karmeli F, Rachmilewitz D, Role of interleukin 1 in inflammatory bowel disease - enhanced production during active disease. Gut 1990; 31:686-9.
4. Murata Y, Ishiguro Y, Itoh J, Munakata A, Yoshida Y, The role of proinflammatory and immunoregulatory cytokines in the pathogenesis of ulcerative colitis. J Gastroenterol 1995; 30 (Suppl. 8):56-60.
5. Mitsuyama K, Toyonaga A, Sasaki E et al. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol 1994; 96:432-6.
6. Schaufelberger HD, Uhr MR, McGuckin C et al. Platelets in ulcerative colitis and Crohn's disease express functional interleukin-1 and interleukin-8 receptors. Eur J Clin Invest 1994; 24:656-63.
7. Daig R, Andus T, Aschenbrenner E, Falk W, Schölmerich J, Gross V. Increased IL-8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 1996; 38:216-22.
8. MacDonald TT, Hutchings P, Choy MY, Murch S, Cooke A. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990; 81:301-5.
9. West GA, Matsuura T, Levine AD, Klein JS, Fiocchi C. Inlerleukin-4 in inflammatory bowel disease and mucosal immune reactivity. Gastroenterology 1496; 110:1683-95.
10. Casini Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-l and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inllammation. J Immunol 1995; 154:2434-40.
11. Andus T, Daig R, Lock G, Scholmerich J, Falk W, Gross V. Balance between pro- and antiinflammatory cytokines in the colonic mucosa in inflammatory bowel disease. Gastroenterology 1995; 108:A770.
12. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995; 109:1344-67.
13. Kuhn R, Lohler J, Rennick D, Rajewsky K, Millier W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993: 75:263-74.
14. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75:253-61.
15. + T cells. Immunity 1994; 1:553-62.
16. Neurath MF, Fuss I, Kelsall BL, Stuber E, Strober W. Antibodies to inlerleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995; 182:1281-90.
17. Okayasu I, Halakeyama S, Yamada M, OhkusaT, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98:694-702.
18. Echtenacher B, Falk W, Manuel DN, Krammer PH. Requirement of endogenous tumor necrosis factor/cacheclin for recovery from experimental peritonitis. J Immunol 1990; 145:3762-6.
19. Geiger T, Towbin H. Cosenti Vargas A et al. Neutralization of interleukin-1 beta activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response. Clin Exp Rheumatol 1993; 11:515-22.
20. Praast G, Hofmeister R, Grube K et al. The internalized interleukin-1 activation complex in fibroblasts localizes to the Golgi Apparatus. J Inflamm 1996; 46:125-38.
21. Jacobs CA, Baker PE, Roux ER et al. Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor. J Immunol 1991: 146:2983-9.
22. Cominelli F, Nast CC, Clark BD et al. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest 1990; 86:972-80.
23. Colotta F, Dower SK, Sims JE, Mantovani A, The type II 'decoy' receptor: a novel regulatory pathway for interleukin I. Immunol Today 1994; 15:562-6.
24. Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 1992; 89:9784-8.
25. van Dullcmen HM, van Deventer SJ, Hommes DW et al Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenlerology 1995; 109:129-35.
26. Deem RL, Shanahan F, Targan SR, Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonie epithelial cells. Clin Exp Immunol 1991; 83:79-84.
27. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. Role of transcriptional activation of I kappa B alpha in mediation of immuno-suppression by glucocorticoids. Science 1995; 270:283-6.
28. Olson AD, DelBuono EA, Bitar KN, Remick DG. Antiserum to tumor necrosis factor and failure to prevent murine colitis. J Pediatr Gastroenterol Nutr 1995; 21:410-8.
29. Echtenacher B, Manuel DN, Hültner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996: 381:75-77.
30. Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG. Anti-tumor necrosis factor antibody therapy fails to prevent lethality alter cecal ligation and puncture or endotoxemia. J Immunol 1992; 148:2724-30.